What is the ICD‑10‑CM code for testing for latent tuberculosis infection?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 7, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

ICD-10-CM Code for Latent Tuberculosis Testing

The ICD-10-CM code for testing for latent tuberculosis infection is Z11.1 (Encounter for screening for respiratory tuberculosis).

Primary Coding for LTBI Screening

When ordering tests specifically to screen for latent tuberculosis infection, Z11.1 is the appropriate encounter code to use for billing and documentation purposes. This code indicates the clinical intent is screening for TB infection in asymptomatic individuals.

Additional Relevant Codes

Depending on the clinical scenario and test results, you may also encounter or need:

  • Z20.1 - Contact with and (suspected) exposure to tuberculosis (use when there is known TB exposure)
  • R76.11 - Nonspecific reaction to tuberculin skin test without active tuberculosis (for positive TST results)
  • R76.12 - Nonspecific reaction to cell mediated immunity measurement of gamma interferon antigen response without active tuberculosis (for positive IGRA results)

Important Coding Pitfalls

Be aware that EHR codes and claims codes for TB-related diagnoses frequently disagree 1. The most common mismatches occur when:

  • EHR codes for LTBI match to claims codes for "TB testing," "pulmonary TB," or "nonspecific positive tuberculin reaction" rather than the intended screening code
  • "Positive tuberculin skin test" appears as an unmatched EHR code
  • "TB screening encounter" appears as the most frequent unmatched claim code

This discordance means approximately 50% of people with TB-related claim codes may not have exact-matched EHR codes 1, which can create documentation and billing challenges.

Clinical Context

The screening code Z11.1 should be used when performing recommended testing methods, which include interferon-gamma release assays (IGRAs) such as QuantiFERON-TB Gold or tuberculin skin tests 2, 3. Current CDC guidance supports using blood-based IGRAs when possible, as they offer greater specificity than TST, particularly in BCG-vaccinated populations 2.

References

Research

Diagnostic code agreement for electronic health records and claims data for tuberculosis.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 2020

Related Questions

In a child who is a close contact of a tuberculosis case and has a positive interferon‑gamma release assay (IGRA) but no clinical or radiographic evidence of active disease, what is the recommended treatment for latent tuberculosis infection?
Should latent tuberculosis infection be treated in a patient with a positive tuberculin skin test (purified protein derivative)?
Given that he has already completed a full course of latent tuberculosis therapy earlier this year, does he need any additional anti‑tuberculosis treatment or further testing?
What are the appropriate ICD‑10 codes for a patient who requires a urine drug screening and tuberculosis screening as part of a school health examination?
What is the difference between Interferon-Gamma Release Assay (IGRA) for Tuberculosis (TB) and the Mantoux test (Tuberculin Skin Test)?
Can you explain functional stenosis, microvascular dysfunction, and endothelial dysfunction?
What are the recommended medications, dosages, concentrations, and routes of administration for treating chronic atrophic gastritis with Helicobacter pylori‑resistant infection according to the latest Brazilian Society of Gastroenterology guidelines?
What is the drug Sibbonti (denosumab) used for?
How can I restart the 441 mg monthly injection of aripiprazole lauroxil (Aristada) after more than two years since the last dose?
What is the appropriate treatment for a 15-year-old with tinea faciei?
How should hypertension be managed in a 67‑year‑old woman with diabetes, chronic heart failure, stage 3 chronic kidney disease, and tremor who is currently taking metoprolol 50 mg daily and propranolol 60 mg three times daily, presenting with mild headache and elevated blood pressure (148/90 mm Hg)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.